Glaxosmithkline | GSK - Ricavi Di Vendita

Prezzo Delle Azioni
52.41
Cambio Giornaliero
-6.71 -11.35%
Mensile
-11.56%
Annuale
35.25%
Q2 Previsione
53.52




I Saldi Cambiamento Data
AbbVie USD 15B 1.62B 2026-03
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bausch Health Companies USD 2.5B 300M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
J&J USD 24.1B 500M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Zoetis USD 2.4B 0 2025-12